Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia.

Autor: Narang S; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Ghebrechristos Y; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Evensen NA; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Murrell N; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Jasinski S; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, NYU Langone Health, New York, NY, USA., Ostrow TH; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Teachey DT; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Raetz EA; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, NYU Langone Health, New York, NY, USA., Lionnet T; Institute for Systems Genetics and Department of Cell Biology, NYU Langone Health, New York, NY, USA.; Department of Biomedical Engineering, NYU Tandon School of Engineering, Brooklyn, NY, USA., Witkowski M; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Aifantis I; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. Ioannis.Aifantis@nyulangone.org.; Department of Pathology, NYU Langone Health, New York, NY, USA. Ioannis.Aifantis@nyulangone.org., Tsirigos A; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. aristotelis.tsirigos@nyulangone.org.; Department of Pathology, NYU Langone Health, New York, NY, USA. aristotelis.tsirigos@nyulangone.org., Carroll WL; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. william.carroll@nyulangone.org.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, NYU Langone Health, New York, NY, USA. william.carroll@nyulangone.org.

Publikováno v: Nature communications [Nat Commun] 2024 Aug 28; Vol. 15 (1), pp. 7425. Date of Electronic Publication: 2024 Aug 28.

SETD2 mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemia.

Autor: Contreras Yametti GP; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Robbins G; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Chowdhury A; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Narang S; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Ostrow TH; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Kilberg H; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Greenberg J; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Kramer L; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Raetz E; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Tsirigos A; Departments of Pediatrics and Pathology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Evensen NA; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Carroll WL; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jan; Vol. 65 (1), pp. 78-90. Date of Electronic Publication: 2024 Jan 10.

Impact of the Multidrug resistance 1 gene polymorphisms on the outcome of therapy in childhood acute leukemia in Duhok province/Iraq.

Autor: Bathyon, Shamoni Robin¹, Eissa, Adil Abozaid² adilkhr77@uod.ac

Publikováno v: Iraqi Journal of Hematology. Jan-Jun2023, Vol. 12 Issue 1, p88-92. 5p.

S100A8 is a prognostic signature and associated with immune response in diffuse large B-cell lymphoma.

Autor: Qi Lin, Jianlin Su, Yuanyuan Fang, Zhihao Zhong, Jie Chen, Chaofeng Zhang

Publikováno v: Frontiers in Oncology; 2024, p1-15, 15p

Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia.

Autor: Bader MS; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.; University of Basel, Basel, Switzerland., Kubetzko S; Division of Oncology, University Children's Hospital, Zürich, Switzerland., Schäfer BW; Division of Oncology, University Children's Hospital, Zürich, Switzerland., Arranto C; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.; University of Basel, Basel, Switzerland., Drexler B; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.; University of Basel, Basel, Switzerland., Halter J; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.; University of Basel, Basel, Switzerland., Passweg JR; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.; University of Basel, Basel, Switzerland., Medinger M; Divisions of Hematology and Internal Medicine, Department of Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. michael.medinger@usb.ch.; University of Basel, Basel, Switzerland. michael.medinger@usb.ch.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Aug 21. Date of Electronic Publication: 2024 Aug 21.